KRO-10948

(1s,2s)-1,2-di(1-naphthyl)-1,2-ethanediol

229184-99-0
98% min.
scale-up (10-1,000 kg)
C22H18O2

KRO-10944

(r,s)-3,5-dimethylphenylethyldiol

196605-90-0
98% min.
scale-up (10-1,000 kg)
C10H13O2 *

KRO-37297

kro-37297


98% min.
scale-up (10-1,000 kg)


KRO-37300

kro-37300


98% min.
scale-up (10-1,000 kg)


KRO-37248

kro-37248


98% min.
scale-up (10-1,000 kg)


KRO-38092

kro-38092


98% min.
scale-up (10-1,000 kg)


KRO-37295

kro-37295


98% min.
scale-up (10-1,000 kg)


KRO-48406

1,3-Cyclohexanedicarboxylic acid; 1,3-Cyclohexanedicarboxylic Acid

3971-31-1
98% min.
scale-up (10-1,000 kg)
C8H12O4

KRO-38300

2-Chloro-5-nitro-3-(trifluoromethyl)pyridine

99368-67-9
98% min.
scale-up (10-1,000 kg)
C6H2ClF3N2O2

KRO-04709

Trelagliptin (USAN); SYR 472; TRELAGLIPTIN; UNII-Q836OWG55H

865759-25-7
98% min.
scale-up (10-1,000 kg)
C18H20FN5O2

KRO-04913

[14C]-Enzalutamide; N-methyl-4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-fluorobenzamide; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide; Enzalutamide; MDV 3100; XTANDI; UNII-93T0T9GKNU; 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide

915087-33-1
98% min.
scale-up (10-1,000 kg)
C21H16F4N4O2S

KRO-04474

Bilatex; Ilaxten; Bilastine; Bilaxten; Bilastine (INN); 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]piperidin-1-yl}ethyl)phenyl]-2-methylpropanoic acid

202189-78-4
98% min.
scale-up (10-1,000 kg)
C28H37N3O3

KRO-04832

Tofacitinib citrate; Tofacitinibcitrate; Xeljanz; CP-690,550-10; Tasocitinib citrate; 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid,3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile; citro

540737-29-9
98% min.
scale-up (10-1,000 kg)
C22H28N6O8

KRO-15801

Carbamic acid, N,​N''-​[[1,​1''-​biphenyl]​-​4,​4''-​diylbis[1H-​imidazole-​5,​2-​diyl-​(2S)​-​2,​1-​pyrrolidinediyl[(1S)​-​1-​(1-​methylethyl)​-​2-​oxo-​2,​1-​ethanediyl]​]​]​bis-​, C,​C''-​dimethyl ester; N,N''-[[1,1''-Biphenyl]-4,4''-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C''-dimethyl ester; BMS-790052; EBP 883; Daclatasvir

1009119-64-5
98% min.
scale-up (10-1,000 kg)
C40H50N8O6

KRO-05733

FC-1271a; Osphena; Fc-1271; Deamino-hydroxytoremifene; Ospemifene; UNII-B0P231ILBK

128607-22-7
98% min.
scale-up (10-1,000 kg)
C24H23ClO2

KRO-11007

Riociguat (JAN/INN); methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate; N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester; Riociguat; Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate; BAY 63-2521; Adempas; UNII-RU3FE2Y4XI

625115-55-1
98% min.
scale-up (10-1,000 kg)
C20H19FN8O2

KRO-03943

Lu AA 21004; 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine; 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine; Vortioxetine

508233-74-7
98% min.
scale-up (10-1,000 kg)
C18H22N2S

KRO-22103

QC-9668

146533-41-7
98% min.
scale-up (10-1,000 kg)
C10H5BrCl2N2

KRO-12773

Sulfamide,propyl; N-propylsulfamide; Propylsulfamide

147962-41-2
98% min.
scale-up (10-1,000 kg)
C3H10N2O2S

KRO-10828

(S)-(-)-2-(N-propylamino)-5-methoxytetralin; (S)-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-propylamine hydrochloride; (-)-(2S)-2-(n-propylamino)-5-methoxytetralin; (S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine; (S)-(-)-2-(N-propylamino)-5-methoxytetraline; (-)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine; (S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine); (S)-(5-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)propylamine

101403-24-1
98% min.
scale-up (10-1,000 kg)
C14H21NO